Value through Innovation

main navigation

jump to content to meta navigation
Headillu

page content

jump to main navigation to meta navigation

Boehringer Ingelheim Press Releases

See the latest Boehringer Ingelheim news releases. To quickly find all news releases on a specific topic, please use the fulltext search.

Press Release Archive

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
05.08.2008 Closure of the tipranavir trials SPRING and TICINO
04.08.2008 New data shows HIV therapy tipranavir (Aptivus®) is effective and well tolerated in children - For medical media, outside the US only
30.07.2008 Dog owners unaware that their pet may be suffering from serious heart disease
15.07.2008 Boehringer Ingelheim FENS Award for Pascal Fries for his exceptional research in neuroscience
26.06.2008 European CHMP issues positive opinion on Cymbalta for the treatment of Generalised Anxiety Disorder - For medical media, outside the US only
26.06.2008 Further steps in generation change at Boehringer Ingelheim
25.06.2008 Following the decision by the Indian Patent Office:
- Boehringer Ingelheim will not legally contest the decision
- Generic manufacture of nevirapine for developing countries permitted since 2007
24.06.2008 New Aptivus® (tipranavir) Oral Solution Approved for Treatment-Experienced Pediatric and Adolescent HIV Patients - For U.S. Media
18.06.2008 Professor Albertino Damasceno is announced as winner of the ISH Boehringer Ingelheim Developing World Award during the 2008 International Society of Hypertension (ISH) Biennial Scientific Meeting
18.06.2008 Micardis®-based regimens help more patients achieve their blood pressure goals - For medical media, outside the US only
17.06.2008 Boehringer Ingelheim to acquire Actimis Pharmaceuticals
10.06.2008 New data shows pramipexole (Mirapexin®/Sifrol®) can significantly reduce limb pain in patients with Restless Legs Syndrome (RLS) - For medical media, outside the US only
09.06.2008 Boehringer Ingelheim announces first positive health technology assessments for novel oral anticoagulant Pradaxa® (dabigatran etexilate) - For medical media, outside the US only
09.06.2008 Closure of the tipranavir POTENT trial
30.05.2008 Boehringer Ingelheim gets first approval within EU for Actilyse® 2mg to treat catheter dysfunction caused by thrombotic occlusion - For medical media, outside the US only
14.05.2008 PRoFESS® results announced at XVII European Stroke Conference - For medical media, outside the US only
07.05.2008 Women suffering from Decreased Sexual Desire:
Silence hinders diagnosis of the prevalent condition Hypoactive Sexual Desire Disorder(HSDD) - For medical media, outside the US only
28.04.2008 European Commission grants full approval of HIV protease inhibitor, tipranavir (Aptivus®) - For medical media, outside the US only
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
back to top

Contact

Boehringer Ingelheim GmbH

Corporate Headquarters
Binger Str. 173
55216 Ingelheim
Germany


Phone +49 / 6132 / 77 0
Fax +49 / 6132 / 72 0

media contacts

RSS feeds allow you to receive latest news and information about Boehringer Ingelheim.

subscribe to RSS Feed